Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Completed · Phase 4
Conditions studied: Neoplasms, Gastric Cancer
In brief
The investigators seek to compare two techniques of removing pre-cancerous lesions from the colon. The investigators also will compare two solutions used during the procedure to determine if either solution allows for an improved removal of the tumors.
Key facts
- Study ID
- NCT01471756
- Run by
- Mayo Clinic
- People needed
- 66
- Starts
- 2011-10-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-09-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Sessile colorectal polyp
- laterally spreading lesions as defined by Paris Classification type II and > 1 cm or greater
You may not qualify if…
- Those with ulcerated depressed lesions (Paris type III) or biopsy proven invasive carcinoma
- Inflammatory bowel disease patients
- Coagulopathy ( INR> 1.5) that cannot be corrected
Where it is running
- Mayo Clinic — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.